US Stock MarketDetailed Quotes
IMMX Immix Biopharma
- 2.010
- -0.100-4.74%
Close Dec 2 16:00 ET
- 2.040
- +0.030+1.49%
Post 16:02 ET
55.29MMarket Cap-2392P/E (TTM)
2.280High1.998Low264.53KVolume2.020Open2.110Pre Close548.55KTurnover1.66%Turnover RatioLossP/E (Static)27.51MShares7.75052wk High3.15P/B32.09MFloat Cap1.26052wk Low--Dividend TTM15.96MShs Float8.680Historical High--Div YieldTTM13.35%Amplitude0.680Historical Low2.073Avg Price1Lot Size
About Immix Biopharma Company
Immix Biopharma, Inc. operates as a biopharmaceutical company that engages in the development of therapies for cancer and inflammatory diseases. The company was founded by Ilya Rachman, Sean Senn, and Vladimir Torchilin in 2012 and is headquartered in Los Angeles, CA.
Company Profile
SymbolIMMX
Company NameImmix Biopharma
Listing DateDec 16, 2021
Issue Price5.00
Founded2012
CEODr. Ilya Rachman
MarketNASDAQ
Employees17
Fiscal Year Ends12-31
Address11400 West Olympic Boulevard,Suite 200
CityLos Angeles
ProvinceCalifornia
CountryUnited States of America
Zip Code90064
Phone1-310-651-8041
Websitehttp://www.immixbio.com
Company Executives
- Name
- Position
- Salary
- Dr. Vladimir Torchilin
- Scientific Co-Founder
- --
- Dr. Ilya Rachman
- Chairman of the Board and Chief Executive Officer
- 2.36M
- Gabriel Morris
- Chief Financial Officer, Principal Accounting Officer and Director
- 2.36M
- Dr. Graham Ross
- Acting Chief Medical Officer and Head of Clinical Development
- --
- Jason Hsu
- Director
- 79.30K
- Dr. Magda Marquet, PhD
- Independent Director
- 89.30K
- Yekaterina Chudnovsky
- Independent Director
- --
- Helen C. Ada C.P.A.
- Independent Director
- 98.15K
- Dr. Carey Ng
- Independent Director
- 82.80K
- Jane M. Buchan, PhD
- Independent Director
- 95.80K
- Nandan Oza
- Head of Chemistry, Manufacturing, and Control
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data